TP53 and cancer: We hypothesize that a specific transcriptional signature is associated with the loss of functional p53 within mutated tumors regardless of their type or tissue of origin since the algorithm stratified 88% of the merged set samples correctly, and the combination of different cancer types as well as the inclusion of both primary and metastatic sets during training enhanced the performance of the model.